Exact Sciences Corporation (BIT:1EXAS)

Exact Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	3,247	2,759	2,500	2,084	1,767
Revenue Growth (YoY)	17.69%	10.37%	19.93%	17.95%	18.49%
Cost of Revenue	984.24	840.15	737.56	661.36	458.76
Gross Profit	2,263	1,919	1,762	1,423	1,308
Selling, General & Admin	1,939	1,676	1,628	1,593	1,663
Depreciation & Amortization Expenses	-	-	-	-	95
Research & Development	523	431.21	426.93	394.19	385.65
Other Operating Expenses	7.2	860.26	-77.81	29.21	20.21
Operating Income	-206.3	-1,049	-215.01	-593.51	-855.68
Interest Income	41.77	39.56	32.71	-19.43	31.78
Interest Expense	-39.36	-27.02	-19.45	-19.63	-18.61
Total Non-Operating Income (Expense)	2.41	12.54	13.27	-39.06	13.17
Pretax Income	-203.89	-1,036	-201.75	-632.57	-842.51
Provision for Income Taxes	-4.06	7.3	-2.4	9.06	246.88
Net Income	-207.95	-1,029	-204.15	-623.51	-595.63
Net Income to Common	-207.95	-1,029	-204.15	-623.51	-595.63
Shares Outstanding (Basic)	189	184	180	176	171
Shares Outstanding (Diluted)	189	184	180	176	171
Shares Change (YoY)	2.44%	2.25%	2.15%	2.92%	13.37%
EPS (Basic)	-1.10	-5.59	-1.13	-3.54	-3.48
EPS (Diluted)	-1.10	-5.59	-1.13	-3.54	-3.48
Free Cash Flow	356.78	74.55	31.93	-438.02	-238
Free Cash Flow Growth	378.60%	133.48%	-	-	-
Free Cash Flow Per Share	1.89	0.40	0.18	-2.48	-1.39
Gross Margin	69.69%	69.55%	70.49%	68.27%	74.04%
Operating Margin	-6.35%	-38.01%	-8.60%	-28.48%	-48.42%
Profit Margin	-6.40%	-37.29%	-8.17%	-29.91%	-33.71%
FCF Margin	10.99%	2.70%	1.28%	-21.02%	-13.47%
EBITDA	-81.42	-929	-100.56	-493.4	-770.33
EBITDA Margin	-2.51%	-33.67%	-4.02%	-23.67%	-43.59%
EBIT	-206.3	-1,049	-215.01	-593.51	-855.68
EBIT Margin	-6.35%	-38.01%	-8.60%	-28.48%	-48.42%
Effective Tax Rate	1.99%	-0.70%	1.19%	-1.43%	-29.30%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.